University of Zurich and University Hospital of Zurich
Zurich, 8001, Switzerland
NCT Number: NCT04618302
This study investigates the test-retest reliability of the lung diffusing capacity for nitric oxide in healthy individuals during exercise.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Zurich, 8001, Switzerland
The aim of this study of to evaluate the test-retest reliability of single-breath lung diffusing capacity measurements for nitric oxide (DLNO) in healthy individuals during light and moderate intensity cycling exercise. Healthy subjects will perform repeated single-breath DLNO measurements during light (i.e., at 50% of the first ventilatory threshold) and moderate intensity exercise (i.e., 80% of the first ventilatory threshold) on a stationary cycle ergometer.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At second study visit
DLNO (in ml/min/mmHg) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
DLNO (in ml/min/mmHg) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
DLNO (in ml/min/mmHg) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
DLNO (in ml/min/mmHg) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
DLCO (in ml/min/mmHg) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
DLCO (in ml/min/mmHg) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
Agreement in DLCO (in ml/min/mmHg) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
Agreement in DLCO (in ml/min/mmHg) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
VA (in L) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
VA (in L) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
Alveolar volume (in L) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
Alveolar volume (in L) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
BHT (in s) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
BHT (in s) measured at 80% of the gas exchange threshold during cycling exercise.
Time frame: At second study visit
BHT (in s) measured at 50% of the gas exchange threshold during cycling exercise.
Time frame: At third study visit, approximately 1-2 weeks after second study visit
BHT (in s) measured at 50% of the gas exchange threshold during cycling exercise.
Thomas Radtke
Other
Test-retest Reliability of Lung Diffusing Capacity for Nitric Oxide During Light and Moderate Intensity Cycling Exercise
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details